Cargando…
Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity
SIMPLE SUMMARY: Recent work has identified the transcription regulator MYB as an interesting therapeutic target for the treatment of certain leukemias and other cancers that are dependent on deregulated MYB activity, such as acute myeloid leukemia (AML) and adenoid cystic carcinoma (ACC). Here we re...
Autores principales: | Yusenko, Maria V., Biyanee, Abhiruchi, Frank, Daria, Köhler, Leonhard H. F., Andersson, Mattias K., Khandanpour, Cyrus, Schobert, Rainer, Stenman, Göran, Biersack, Bernhard, Klempnauer, Karl-Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750090/ https://www.ncbi.nlm.nih.gov/pubmed/35008207 http://dx.doi.org/10.3390/cancers14010043 |
Ejemplares similares
-
Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities
por: Köhler, Leonhard H. F., et al.
Publicado: (2023) -
Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner
por: Biyanee, Abhiruchi, et al.
Publicado: (2022) -
Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins
por: Cibis, Hannah, et al.
Publicado: (2020) -
A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity
por: Yusenko, Maria, et al.
Publicado: (2018) -
Translation, Pdcd4 and eIF4A
por: Biyanee, Abhiruchi, et al.
Publicado: (2015)